Juan R. Cubillos‐Ruiz

Author

Also Known As

Cubillos-Ruiz, Juan R, J. Cubillos-Ruiz, J.R. CUBILLOS-RUIZ, J.R. Cubillos-Ruiz, Juan Cubillos-Ruiz, Juan R Cubillos-Ruiz, Juan R Cubillos‐Ruiz, Juan R. Cubillos-Ruiz, Juan R. Cubillos‐Ruiz, Juan R. Cubillos-Ruiz

179

Publications

15.8K

Citations

H-Index

Concepts

All Affiliations

Cornell University Weill Cornell Medicine The Wistar Institute Memorial Sloan Kettering Cancer Center Moffitt Cancer Center

About

Juan R. Cubillos‐Ruiz is an author at Cornell University specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	4.6K
2	Engineering	2	2	1.6K
3	Natural Sciences	1	1	29
4	Biochemistry	1	1	29
5	Biomolecular Engineering	1	1	33

Juan R. Cubillos‐Ruiz

Publications

6.2K

Citations

H-Index

Page 1

	Year	Citations
Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation Haiying Zhang, Daniela Freitas, Han Sang Kim, Nature Cell Biology NanoparticlesExtracellular VesiclesEngineeringMedicineField-flow Fractionation	2018	1.6K
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis Juan R. Cubillos‐Ruiz, Pedro C. Silberman, Melanie R. Rutkowski, Cell Cancer ImmunosurveillanceSignal TransductionCell RegulationImmunologyTumor Immunity	2015	891
IRE1α–XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity Minkyung Song, Tito A. Sandoval, Chang-Suk Chae, Nature Cancer MetabolismMitochondrial FunctionMitochondrial ActivityT Cell FunctionMedicine	2018	389
Somatic mutations and cell identity linked by Genotyping of Transcriptomes Anna S. Nam, Kyu-Tae Kim, Ronan Chaligné, Nature Developmental BiologySomatic MutationsSomatic VariantSomatic Cell GeneticsMedicine	2019	320
Ovarian cancer progression is controlled by phenotypic changes in dendritic cells Uciane K. Scarlett, Melanie R. Rutkowski, Adam M. Rauwerdink, The Journal of Experimental Medicine ImmunologyImmunoeditingGynecologyOvarian Cancer ProgressionImmunotherapy	2012	305
The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling Eslam Mohamed, Rosa A. Sierra, Jimena Trillo-Tinoco, Immunity Cancer ImmunosurveillanceSignal TransductionReceptor Tyrosine KinaseImmunologyImmunotherapy	2020	210
Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity Juan R. Cubillos‐Ruiz, Xavier Engle, Uciane K. Scarlett, Journal of Clinical Investigation ImmunologyImmunoeditingImmunotherapeuticsImmunotherapyTumor Biology	2009	207
Antifungal mechanisms by which a novel <i>Pseudomonas aeruginosa</i> phenazine toxin kills <i>Candida albicans</i> in biofilms Diana K. Morales, Nicholas J. Jacobs, Sathish Rajamani, Molecular Microbiology	2010	152
BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells Kyle K. Payne, Jessica A. Mine, Subir Biswas, Science	2020	151
ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression Yu Cao, Jimena Trillo-Tinoco, Rosa A. Sierra, Nature Communications	2019	150

Page 1